GL1X · GenesisL1 explorer

MolNFT v1 · #182693 · protein

Crystal structure of MTH1 in complex with compound 32

7N13 · 7,8-dihydro-8-oxoguanine triphosphatase: “Crystal structure of MTH1 in complex with compound 32”. X-ray diffraction, 2 ligands (ZRV, SO4), 3 pockets (best druggability 0.73). MolNFT v1 #182693 on GenesisL1: 3D structure, binding…

PDB
7N13
Type
protein
Length
309 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
7,8-dihydro-8-oxoguanine triphosphatase
EC
3.6.1.55, 3.6.1.56
UniProt
P36639
Ligands
ZRV, SO4
Pockets
3 · best druggability 0.73

Structure

x-ray diffraction · 2 distinct chains · 17% helix, 46% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A7,8-dihydro-8-oxoguanine triphosphatase (EC 3.6.1.55, 3.6.1.56)protein15516% helix, 46% strandP36639
B7,8-dihydro-8-oxoguanine triphosphatase (EC 3.6.1.55, 3.6.1.56)protein15418% helix, 45% strandP36639

Ligands and binding sites

  • ZRV · 4-anilino-6-[4-(butylcarbamoyl)-3-fluorophenyl]-N-cyclopropyl-7-fluoroquinoline-3-carboxamide · ligand · 2 copies · chains A, B
  • SO4 · Sulfate ion · ion · 6 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11910.730.8933ZRV
21940.720.8833ZRV
3760.320.7417empty

Interfaces

1 interface between chains.

  • A–B · 461 Ų buried · 9 hydrogen bonds · protein-protein

Compared structures

  • 7N13 · Crystal structure of MTH1 in complex with compound 32 · the same entry in another collection · chain A against A, TM-score 1.00
  • P36639 · AlphaFold monomer V2.0 prediction for 7,8-dihydro-8-oxoguanine triphosphatase (P36639) · a predicted model of the same protein · chain B against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.